PNC Financial Services Group’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $41.9K | Buy |
1,476
+1,099
| +292% | +$31.2K | ﹤0.01% | 3203 |
|
|
2025
Q1 | $11.1K | Sell |
377
-75
| -17% | -$2.21K | ﹤0.01% | 3790 |
|
|
2024
Q4 | $13.1K | Buy |
452
+41
| +10% | +$1.19K | ﹤0.01% | 3703 |
|
|
2024
Q3 | $18.9K | Buy |
411
+326
| +384% | +$15K | ﹤0.01% | 3539 |
|
|
2024
Q2 | $3.47K | Buy |
85
+31
| +57% | +$1.27K | ﹤0.01% | 4102 |
|
|
2024
Q1 | $1.38K | Buy |
54
+18
| +50% | +$459 | ﹤0.01% | 4294 |
|
|
2023
Q4 | $326 | Buy |
+36
| New | +$326 | ﹤0.01% | 4452 |
|